Innova Medical Group, an innovative MedTech on a global scale
The Innova Medical Group is a specialist in innovative solutions for the rapid screening and diagnosis of infectious diseases, chronic diseases, and everyday health and wellness.
A pioneer in the fight against Covid-19 with more than 2.5 billion units sold in 2 years, Innova Medical Group has expanded its offerings to include a wide range of rapid tests for SARS-CoV-2, influenza and strep throat, as well as a complete line of self-tests for everyday health and wellness.
In France, an assembly and packaging site for its tests, with a production capacity of up to 5 million tests per month, was inaugurated in October 2021 in Pithiviers, in the Loiret region, in the heart of Europe’s leading pharmaceutical cluster, Polepharma.
By the end of 2022, Innova Medical Group will continue to expand and proactively work to bring other innovative screening and rapid diagnostic solutions to market.
Vision
Innova Medical Group believes in innovative screening and rapid diagnosis for the benefit of all and accessible to the greatest number.
Innova is a leading international player in the field of screening and rapid diagnosis, positioning itself as a catalyst and booster of innovations for increased health prevention, with the ability to market a wide range of screening and rapid diagnostic solutions on a large scale for healthcare professionals and the general public via self-tests.
Our screening and rapid diagnostic solutions aim to empower people to take a more active role in their healthcare sometimes incorporating digital technology in order to optimize benefits such as prevention, ease of use, time savings and personalized support.
